Target intelligence / Profile preview

Neurofibromin 1 pre-messenger RNA splice-regulatory sequence (NF1 pre-mRNA)

Target
NF1 pre-mRNA
Molecular classification
RNA, Splice-regulatory element
01

Overview

The Neurofibromin 1 (NF1) pre-mRNA splice-regulatory sequence refers to the cis-acting elements within the NF1 primary transcript that coordinate the assembly of the spliceosome to produce mature mRNA. The NF1 gene encodes neurofibromin, a large protein that acts as a negative regulator of the RAS/MAPK signaling pathway by accelerating the hydrolysis of RAS-GTP (Messiaen et al., 2000; PubMed PMID: 10903931). Mutations affecting these splice-regulatory sequences—including those at canonical splice sites, exonic splicing enhancers (ESEs), or deep intronic regions that create cryptic splice sites—account for approximately 30-50% of all Neurofibromatosis type 1 cases (Wimmer et al., 2007; PubMed PMID: 17311295). These splicing defects typically lead to the production of truncated, non-functional neurofibromin, resulting in the clinical hallmarks of NF1 such as café-au-lait spots, neurofibromas, and an increased risk of malignant peripheral nerve sheath tumors (Pros et al., 2009; PubMed PMID: 19105186). Therapeutic strategies targeting these sequences involve the use of antisense oligonucleotides (ASOs) or splice-switching oligonucleotides (SSOs) designed to bind and mask specific regulatory motifs. By sterically blocking aberrant splice sites or enhancing the recognition of weak exons, these agents aim to restore the correct reading frame and increase the expression of functional neurofibromin protein (Castellanos et al., 2013; PubMed PMID: 23430918).

Other names
NF1 splicing elementNF1 pre-mRNA regulatory sequenceNeurofibromin 1 mRNA precursorNF1 splice site
02

Mechanism of action

Splice modulation via steric hindrance of regulatory elements to restore correct mRNA processing.

03

Biological functions

RNA splicingGene expression regulationTumor suppression
04

Disease associations

Neurofibromatosis type 1Malignant peripheral nerve sheath tumorOptic pathway gliomaCancer
05

Safety considerations

Off-target RNA bindingDelivery to the central and peripheral nervous systemImmunogenicity of synthetic oligonucleotides
06

Interacting drugs

Antisense oligonucleotides (experimental)

1 more in the full profile.

07

Biomarkers

NF1 mRNA isoform ratioNeurofibromin protein expression levelsRAS-GTP activity levelsp-ERK/p-MEK signaling levels

Beyond the preview

Go deeper on Neurofibromin 1 pre-messenger RNA splice-regulatory sequence (NF1 pre-mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurofibromin 1 pre-messenger RNA splice-regulatory sequence (NF1 pre-mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call